AIM ImmunoTech Announces Central IRB Approval of Phase 2 Study Protocol Evaluating Ampligen® for the Treatment of Post-COVID Conditions
This entry was posted by admin on April 4, 2023 at 8:57 pm
- Tags:
Ampligen®, announces, approval, Central, conditions, Evaluating, ImmunoTech, phase, PostCOVID, protocol, study, treatment
- Categories:
Breaking
){kind=link}
Comments
Comments are disabled for this post.